Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-12-10 09:10 am Sale | 13G | ACORDA THERAPEUTICS INC ACOR | VANGUARD GROUP INC | 2,261,420 4.72% | -2,782,218 (-55.16%) | View |
2020-08-10 09:25 am Sale | 13G | ACORDA THERAPEUTICS INC ACOR | FMR LLC | 55,217 0.114% | -2,865,640 (-98.11%) | View |
2020-07-10 10:39 am Sale | 13G | ACORDA THERAPEUTICS INC ACOR | BlackRock Inc. BLK | 1,145,305 2.4% | -2,095,207 (-64.66%) | View |
2020-06-10 10:13 am Sale | 13G | ACORDA THERAPEUTICS INC ACOR | FMR LLC | 2,920,857 6.08% | -3,509,433 (-54.58%) | View |
2020-06-09 4:32 pm Sale | 13G | ACORDA THERAPEUTICS INC ACOR | BlackRock Inc. BLK | 3,240,512 6.8% | -4,598,664 (-58.66%) | View |
2020-02-14 4:05 pm Sale | 13G | ACORDA THERAPEUTICS INC ACOR | PFM Health Sciences LP | 1,911,742 4% | -969,918 (-33.66%) | View |
2020-02-13 6:36 pm Sale | 13G | ACORDA THERAPEUTICS INC ACOR | STATE STREET CORP STT | 1,469,088 3.06% | -1,225,993 (-45.49%) | View |
2020-02-12 12:28 pm Purchase | 13G | ACORDA THERAPEUTICS INC ACOR | RENAISSANCE TECHNOLOGIES LLC | 3,857,250 8.03% | 3,857,250 (New Position) | View |
2020-02-12 10:26 am Purchase | 13G | ACORDA THERAPEUTICS INC ACOR | DIMENSIONAL FUND ADVISORS LP | 2,985,489 6.22% | 82,396 (+2.84%) | View |
2020-02-11 7:24 pm Sale | 13G | ACORDA THERAPEUTICS INC ACOR | VANGUARD GROUP INC | 5,043,638 10.5% | -1,059,717 (-17.36%) | View |
2020-02-07 11:12 am Sale | 13G | ACORDA THERAPEUTICS INC ACOR | FMR LLC | 6,430,290 13.372% | -679,643 (-9.56%) | View |
2020-02-04 11:53 am Purchase | 13G | ACORDA THERAPEUTICS INC ACOR | BlackRock Inc. BLK | 7,839,176 16.3% | 1,167,330 (+17.50%) | View |
2020-01-15 12:15 pm Purchase | 13G | ACORDA THERAPEUTICS INC ACOR | SYMPHONY ASSET MANAGEMENT LLC | 4,633,427 9.647% | 4,633,427 (New Position) | View |
2020-01-13 09:08 am Purchase | 13G | ACORDA THERAPEUTICS INC ACOR | CANYON CAPITAL ADVISORS LLC | 7,821,426 14% | 7,821,426 (New Position) | View |
2020-01-02 5:10 pm Purchase | 13G | ACORDA THERAPEUTICS INC ACOR | Point72 Asset Management L.P. | 4,701,928 9.8% | 4,701,928 (New Position) | View |
2019-11-12 4:11 pm Sale | 13G | ACORDA THERAPEUTICS INC ACOR | SCOPIA CAPITAL MANAGEMENT LP | 0 0% | -4,653,551 (Position Closed) | View |